Eurofins-Cerep SA
ALECR
Company Profile
Business description
Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.
Contact
Le bois l Eveque
Celle l Evescault86600
FRAT: +33 549893000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
207
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,637.50 | 22.80 | -0.26% |
| CAC 40 | 7,714.30 | 37.59 | -0.48% |
| DAX 40 | 23,923.66 | 73.82 | -0.31% |
| Dow JONES (US) | 42,270.07 | 54.34 | 0.13% |
| FTSE 100 | 8,784.84 | 12.46 | 0.14% |
| HKSE | 23,157.97 | 131.80 | -0.57% |
| NASDAQ | 19,113.77 | 62.10 | -0.32% |
| Nikkei 225 | 37,470.67 | 494.43 | -1.30% |
| NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
| S&P 500 | 5,911.69 | 0.48 | -0.01% |
| S&P/ASX 200 | 8,414.10 | 20.60 | -0.24% |
| SSE Composite Index | 3,347.49 | 15.96 | -0.47% |